{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:39:08Z","timestamp":1792535948143,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"43","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,11,11]]},"DOI":"10.1038\/s41388-026-03981-9","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:36:50Z","timestamp":1789457810000},"page":"4673-4688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CircLAMA5 traps Sam68 in the cytoplasm to regulate alternative splicing and drive sunitinib resistance in ccRCC"],"prefix":"10.1038","volume":"45","author":[{"given":"Zhehao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9881-9561","authenticated-orcid":false,"given":"Yudong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenshuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1606-1519","authenticated-orcid":false,"given":"Lifeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9845-7241","authenticated-orcid":false,"given":"Gonghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5040-4992","authenticated-orcid":false,"given":"Liqun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"3981_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009.","journal-title":"Nat Rev Dis Primers"},{"key":"3981_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100929","volume":"67","author":"J Jin","year":"2023","unstructured":"Jin J, Xie Y, Zhang JS, Wang JQ, Dai SJ, He WF, et al. Sunitinib resistance in renal cell carcinoma: from molecular mechanisms to predictive biomarkers. Drug Resist Updat. 2023;67:100929.","journal-title":"Drug Resist Updat"},{"key":"3981_CR3","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/bph.16252","volume":"180","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu X, Gong L, Ding W, Hao W, Peng Y, et al. Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics. Br J Pharmacol. 2023;180:2937\u201355.","journal-title":"Br J Pharmacol"},{"key":"3981_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15586\/jkcvhl.2014.7","volume":"1","author":"C Morais","year":"2014","unstructured":"Morais C. Sunitinib resistance in renal cell carcinoma. J Kidney Cancer VHL. 2014;1:1\u201311.","journal-title":"J Kidney Cancer VHL"},{"key":"3981_CR5","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1080\/15548627.2015.1085742","volume":"11","author":"S Giuliano","year":"2015","unstructured":"Giuliano S, Cormerais Y, Dufies M, Gr\u00e9pin R, Colosetti P, Belaid A, et al. Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux. Autophagy. 2015;11:1891\u2013904.","journal-title":"Autophagy"},{"key":"3981_CR6","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.3390\/ijms22126467","volume":"22","author":"M Rausch","year":"2021","unstructured":"Rausch M, Rutz A, Allard PM, Delucinge-Vivier C, Docquier M, Dormond O, et al. Molecular and functional analysis of sunitinib-resistance induction in human renal cell carcinoma cells. Int J Mol Sci. 2021;22:6467.","journal-title":"Int J Mol Sci"},{"key":"3981_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675\u201391.","journal-title":"Nat Rev Genet"},{"key":"3981_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","volume":"21","author":"LL Chen","year":"2020","unstructured":"Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21:475\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3981_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41418-022-00948-7","volume":"29","author":"S Misir","year":"2022","unstructured":"Misir S, Wu N, Yang BB. Specific expression and functions of circular RNAs. Cell Death Differ. 2022;29:481\u201391.","journal-title":"Cell Death Differ"},{"key":"3981_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.790589","volume":"11","author":"XY Liu","year":"2021","unstructured":"Liu XY, Zhang Q, Guo J, Zhang P, Liu H, Tian ZB, et al. The role of circular RNAs in the drug resistance of cancers. Front Oncol. 2021;11:790589.","journal-title":"Front Oncol"},{"key":"3981_CR11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/cancers14040866","volume":"14","author":"G Long","year":"2022","unstructured":"Long G, Ma S, Shi R, Sun Y, Hu Z, Chen K. Circular RNAs and drug resistance in genitourinary cancers: a literature review. Cancers. 2022;14:866.","journal-title":"Cancers"},{"key":"3981_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01266-7","volume":"19","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang Y, Wang P, Fu X, Lin W. Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy. Mol Cancer. 2020;19:149.","journal-title":"Mol Cancer"},{"key":"3981_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.canlet.2021.10.003","volume":"523","author":"KB Huang","year":"2021","unstructured":"Huang KB, Pan YH, Shu GN, Yao HH, Liu X, Zhou M, et al. Circular RNA circSNX6 promotes sunitinib resistance in renal cell carcinoma through the miR-1184\/GPCPD1\/lysophosphatidic acid axis. Cancer Lett. 2021;523:121\u201334.","journal-title":"Cancer Lett"},{"key":"3981_CR14","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1038\/s41388-022-02386-8","volume":"41","author":"MX Zhang","year":"2022","unstructured":"Zhang MX, Wang JL, Mo CQ, Mao XP, Feng ZH, Li JY, et al. CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1. Oncogene. 2022;41:3979\u201390.","journal-title":"Oncogene"},{"key":"3981_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05717-z","volume":"14","author":"Y Shou","year":"2023","unstructured":"Shou Y, Yue C, Wang Q, Liu J, Xu J, Miao Q, et al. circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM\/IL-6\/STAT3 pathway. Cell Death Dis. 2023;14:232.","journal-title":"Cell Death Dis"},{"key":"3981_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1512","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu Y, Chen K, Shou Y, Li S, Wang J, Zhang Q, et al. circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma. Clin Transl Med. 2023;13:e1512.","journal-title":"Clin Transl Med"},{"key":"3981_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100728","volume":"53","author":"R Sciarrillo","year":"2020","unstructured":"Sciarrillo R, Wojtuszkiewicz A, Assaraf YG, Jansen G, Kaspers GJL, Giovannetti E, et al. The role of alternative splicing in cancer: from oncogenesis to drug resistance. Drug Resist Updat. 2020;53:100728.","journal-title":"Drug Resist Updat"},{"key":"3981_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","volume":"17","author":"SC Bonnal","year":"2020","unstructured":"Bonnal SC, L\u00f3pez-Oreja I, Valc\u00e1rcel J. Roles and mechanisms of alternative splicing in cancer - implications for care. Nat Rev Clin Oncol. 2020;17:457\u201374.","journal-title":"Nat Rev Clin Oncol"},{"key":"3981_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-021-00486-7","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Qian J, Gu C, Yang Y. Alternative splicing and cancer: a systematic review. Signal Transduct Target Ther. 2021;6:78.","journal-title":"Signal Transduct Target Ther"},{"key":"3981_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1083\/jcb.200701005","volume":"176","author":"MP Paronetto","year":"2007","unstructured":"Paronetto MP, Achsel T, Massiello A, Chalfant CE, Sette C. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. J Cell Biol. 2007;176:929\u201339.","journal-title":"J Cell Biol"},{"key":"3981_CR21","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1002\/cam4.4743","volume":"11","author":"Z Wu","year":"2022","unstructured":"Wu Z, Peng Y, Xiong L, Wang J, Li Z, Ning K, et al. Role of Sam68 in sunitinib induced renal cell carcinoma apoptosis. Cancer Med. 2022;11:3674\u201386.","journal-title":"Cancer Med"},{"key":"3981_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01549-1","volume":"21","author":"Y Chen","year":"2022","unstructured":"Chen Y, Lu Z, Qi C, Yu C, Li Y, Huan W, et al. N(6)-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma. Mol Cancer. 2022;21:111.","journal-title":"Mol Cancer"},{"key":"3981_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101150","volume":"77","author":"X Zeng","year":"2024","unstructured":"Zeng X, Chen Z, Zhu Y, Liu L, Zhang Z, Xiao Y, et al. O-GlcNAcylation regulation of RIPK1-dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma. Drug Resist Updat. 2024;77:101150.","journal-title":"Drug Resist Updat"},{"key":"3981_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04366-4","volume":"12","author":"LJ Gong","year":"2021","unstructured":"Gong LJ, Wang XY, Yao XD, Wu X, Gu WY. CircESRP1 inhibits clear cell renal cell carcinoma progression through the CTCF-mediated positive feedback loop. Cell Death Dis. 2021;12:1081.","journal-title":"Cell Death Dis"},{"key":"3981_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.21037\/atm.2020.03.108","volume":"8","author":"J Zhao","year":"2020","unstructured":"Zhao J, Li J, Hassan W, Xu D, Wang X, Huang Z. Sam68 promotes aerobic glycolysis in colorectal cancer by regulating PKM2 alternative splicing. Ann Transl Med. 2020;8:459.","journal-title":"Ann Transl Med"},{"key":"3981_CR26","doi-asserted-by":"publisher","first-page":"e15018","DOI":"10.7554\/eLife.15018","volume":"5","author":"K Fu","year":"2016","unstructured":"Fu K, Sun X, Wier EM, Hodgson A, Liu Y, Sears CL, et al. Sam68\/KHDRBS1 is critical for colon tumorigenesis by regulating genotoxic stress-induced NF-\u03baB activation. Elife. 2016;5:e15018.","journal-title":"Elife"},{"key":"3981_CR27","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","volume":"19","author":"RV Honorato","year":"2024","unstructured":"Honorato RV, Trellet ME, Jim\u00e9nez-Garc\u00eda B, Schaarschmidt JJ, Giulini M, Reys V, et al. The HADDOCK2.4 web server for integrative modeling of biomolecular complexes. Nat Protoc. 2024;19:3219\u201341.","journal-title":"Nat Protoc"},{"key":"3981_CR28","doi-asserted-by":"publisher","first-page":"38639","DOI":"10.1074\/jbc.M505802200","volume":"280","author":"KE Lukong","year":"2005","unstructured":"Lukong KE, Larocque D, Tyner AL, Richard S. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. J Biol Chem. 2005;280:38639\u201347.","journal-title":"J Biol Chem"},{"key":"3981_CR29","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1091\/mbc.10.9.3015","volume":"10","author":"T Chen","year":"1999","unstructured":"Chen T, Boisvert FM, Bazett-Jones DP, Richard S. A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines. Mol Biol Cell. 1999;10:3015\u201333.","journal-title":"Mol Biol Cell"},{"key":"3981_CR30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nature01153","volume":"420","author":"N Matter","year":"2002","unstructured":"Matter N, Herrlich P, K\u00f6nig H. Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature. 2002;420:691\u20135.","journal-title":"Nature"},{"key":"3981_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.638149","volume":"8","author":"A Mboukou","year":"2021","unstructured":"Mboukou A, Rajendra V, Kleinova R, Tisn\u00e9 C, Jantsch MF, Barraud P. Transportin-1: a nuclear import receptor with moonlighting functions. Front Mol Biosci. 2021;8:638149.","journal-title":"Front Mol Biosci"},{"key":"3981_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201706759","volume":"30","author":"RH Fang","year":"2018","unstructured":"Fang RH, Kroll AV, Gao W, Zhang L. Cell membrane coating nanotechnology. Adv Mater. 2018;30:e1706759.","journal-title":"Adv Mater"},{"key":"3981_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100633","volume":"20","author":"S Zeng","year":"2023","unstructured":"Zeng S, Tang Q, Xiao M, Tong X, Yang T, Yin D, et al. Cell membrane-coated nanomaterials for cancer therapy. Mater Today Bio. 2023;20:100633.","journal-title":"Mater Today Bio"},{"key":"3981_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn3333","volume":"8","author":"Q Wang","year":"2022","unstructured":"Wang Q, Wang H, Yan H, Tian H, Wang Y, Yu W, et al. Suppression of osteoclast multinucleation via a posttranscriptional regulation-based spatiotemporally selective delivery system. Sci Adv. 2022;8:eabn3333.","journal-title":"Sci Adv"},{"key":"3981_CR35","doi-asserted-by":"publisher","first-page":"e2311760.","DOI":"10.1002\/adma.202311760","volume":"36","author":"M Song","year":"2024","unstructured":"Song M, Tian J, Wang L, Dong S, Fu K, Chen S, et al. Efficient delivery of lomitapide using hybrid membrane-coated tetrahedral DNA nanostructures for glioblastoma therapy. Adv Mater. 2024;36:e2311760.","journal-title":"Adv Mater"},{"key":"3981_CR36","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","volume":"92","author":"O Boussif","year":"1995","unstructured":"Boussif O, Lezoualc\u2019h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA. 1995;92:7297\u2013301.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3981_CR37","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/jgm.773","volume":"7","author":"M Neu","year":"2005","unstructured":"Neu M, Fischer D, Kissel T. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med. 2005;7:992\u20131009.","journal-title":"J Gene Med"},{"key":"3981_CR38","first-page":"73","volume":"1653","author":"KE Lukong","year":"2003","unstructured":"Lukong KE, Richard S. Sam68, the KH domain-containing superSTAR. Biochim Biophys Acta. 2003;1653:73\u201386.","journal-title":"Biochim Biophys Acta"},{"key":"3981_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0014-5793(97)00455-9","volume":"409","author":"T Ishidate","year":"1997","unstructured":"Ishidate T, Yoshihara S, Kawasaki Y, Roy BC, Toyoshima K, Akiyama T. Identification of a novel nuclear localization signal in Sam68. FEBS Lett. 1997;409:237\u201341.","journal-title":"FEBS Lett"},{"key":"3981_CR40","doi-asserted-by":"publisher","first-page":"13045","DOI":"10.1093\/nar\/gkac1181","volume":"50","author":"I Malki","year":"2022","unstructured":"Malki I, Liepina I, Kogelnik N, Watmuff H, Robinson S, Lightfoot A, et al. Cdk1-mediated threonine phosphorylation of Sam68 modulates its RNA binding, alternative splicing activity and cellular functions. Nucleic Acids Res. 2022;50:13045\u201362.","journal-title":"Nucleic Acids Res"},{"key":"3981_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1407-6","volume":"10","author":"CFA Warren","year":"2019","unstructured":"Warren CFA, Wong-Brown MW, Bowden NA. BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis. 2019;10:177.","journal-title":"Cell Death Dis"},{"key":"3981_CR42","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13046-021-02001-w","volume":"40","author":"Z Dou","year":"2021","unstructured":"Dou Z, Zhao D, Chen X, Xu C, Jin X, Zhang X, et al. Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation. J Exp Clin Cancer Res. 2021;40:194.","journal-title":"J Exp Clin Cancer Res"},{"key":"3981_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/embr.201338241","volume":"15","author":"P Bielli","year":"2014","unstructured":"Bielli P, Bus\u00e0 R, Di Stasi SM, Munoz MJ, Botti F, Kornblihtt AR, et al. The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis. EMBO Rep. 2014;15:419\u201327.","journal-title":"EMBO Rep"},{"key":"3981_CR44","doi-asserted-by":"publisher","first-page":"116805.","DOI":"10.1016\/j.biopha.2024.116805","volume":"175","author":"A Kowalewski","year":"2024","unstructured":"Kowalewski A, Borowczak J, Maniewski M, Gostomczyk K, Grzanka D, Szylberg \u0141. Targeting apoptosis in clear cell renal cell carcinoma. Biomed Pharmacother. 2024;175:116805.","journal-title":"Biomed Pharmacother"},{"key":"3981_CR45","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1158\/0008-5472.CAN-08-4323","volume":"69","author":"H Xin","year":"2009","unstructured":"Xin H, Zhang C, Herrmann A, Du Y, Figlin R, Yu H. Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res. 2009;69:2506\u201313.","journal-title":"Cancer Res"},{"key":"3981_CR46","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/cancers11121836","volume":"11","author":"JC Harris","year":"2019","unstructured":"Harris JC, Scully MA, Day ES. Cancer cell membrane-coated nanoparticles for cancer management. Cancers. 2019;11:1836.","journal-title":"Cancers"},{"key":"3981_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2023;20:33\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"3981_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1285","volume":"13","author":"N Krishnan","year":"2023","unstructured":"Krishnan N, Fang RH, Zhang L. Cell membrane-coated nanoparticles for the treatment of cancer. Clin Transl Med. 2023;13:e1285.","journal-title":"Clin Transl Med"},{"key":"3981_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26052-x","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu L, Bai X, Martikainen MV, K\u00e5rlund A, Roponen M, Xu W, et al. Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles. Nat Commun. 2021;12:5726.","journal-title":"Nat Commun"},{"key":"3981_CR50","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/B978-0-12-418687-3.00018-5","volume":"529","author":"PA Longo","year":"2013","unstructured":"Longo PA, Kavran JM, Kim MS, Leahy DJ. Transient mammalian cell transfection with polyethylenimine (PEI). Methods Enzymol. 2013;529:227\u201340.","journal-title":"Methods Enzymol"},{"key":"3981_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20\u201337.","journal-title":"Nat Rev Cancer"},{"key":"3981_CR52","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.3390\/cancers11121855","volume":"11","author":"L Salvioni","year":"2019","unstructured":"Salvioni L, Rizzuto MA, Bertolini JA, Pandolfi L, Colombo M, Prosperi D. Thirty years of cancer nanomedicine: success, frustration, and hope. Cancers. 2019;11:1855.","journal-title":"Cancers"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03981-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03981-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03981-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:03:06Z","timestamp":1792533786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03981-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":52,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2026,11,11]]}},"alternative-id":["3981"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03981-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were performed in accordance with the relevant institutional guidelines and regulations of Zhejiang University and were approved by the Ethics Committee of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (SRRSH202202329).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}